FR2866025B1 - Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras - Google Patents

Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras

Info

Publication number
FR2866025B1
FR2866025B1 FR0502484A FR0502484A FR2866025B1 FR 2866025 B1 FR2866025 B1 FR 2866025B1 FR 0502484 A FR0502484 A FR 0502484A FR 0502484 A FR0502484 A FR 0502484A FR 2866025 B1 FR2866025 B1 FR 2866025B1
Authority
FR
France
Prior art keywords
genome
proteins
associated coronavirus
coronavirus strain
peptides coded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0502484A
Other languages
English (en)
Other versions
FR2866025A1 (fr
Inventor
Der Werf Sylvie Van
Nicolas Escriou
Chaigne Bernadette Crescenzo
Jean Claude Manuguerra
Franck Kunst
Benoit Callendret
Jean Michel Betton
Valerie Lorin
Sylvie Gerbaud
Ana Maria Burguiere
Saliha Azebi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0502484A priority Critical patent/FR2866025B1/fr
Publication of FR2866025A1 publication Critical patent/FR2866025A1/fr
Application granted granted Critical
Publication of FR2866025B1 publication Critical patent/FR2866025B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002Coronaviridae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/165Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
FR0502484A 2005-03-14 2005-03-14 Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras Expired - Fee Related FR2866025B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0502484A FR2866025B1 (fr) 2005-03-14 2005-03-14 Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502484A FR2866025B1 (fr) 2005-03-14 2005-03-14 Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras

Publications (2)

Publication Number Publication Date
FR2866025A1 FR2866025A1 (fr) 2005-08-12
FR2866025B1 true FR2866025B1 (fr) 2010-12-10

Family

ID=34778724

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0502484A Expired - Fee Related FR2866025B1 (fr) 2005-03-14 2005-03-14 Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras

Country Status (1)

Country Link
FR (1) FR2866025B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111505277A (zh) * 2020-03-10 2020-08-07 四川省人民医院 2019新型冠状病毒IgG抗体检测试剂盒
CN112034174B (zh) * 2020-03-20 2024-03-29 中国人民解放军军事科学院军事医学研究院 一种多肽芯片及其在病毒检测上的应用
CN111413495B (zh) * 2020-05-18 2021-06-04 博奥赛斯(天津)生物科技有限公司 一种新型冠状病毒IgM/IgG胶体金检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897744B2 (en) * 2003-04-28 2011-03-01 The Public Health Agency Of Canada SARS virus nucleotide and amino acid sequences and uses thereof

Also Published As

Publication number Publication date
FR2866025A1 (fr) 2005-08-12

Similar Documents

Publication Publication Date Title
ATE529441T1 (de) Expression von proteinen in e.coli
DE60226724D1 (de) Antimikrobielles polypeptid
DE60310731D1 (de) Neue, von noraporphin abgeleitete moleküle
ATE348201T1 (de) Martensitischer nichtrostender stahl
ATE330017T1 (de) Kallikrein gen
WO2002068465A3 (fr) Nouvelle proteine pouvant etre induite par p53
FR2866025B1 (fr) Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras
DE60213132D1 (de) Puffer-torkran
AU2003216184A8 (en) Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
ATE301814T1 (de) Sicherung für eine pistole
FI20050292A (fi) Kuorma-ajoneuvon pankko
ATE489401T1 (de) Pegyliertes t20-polypeptid
ATE429431T1 (de) 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
FR2862974B1 (fr) Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras
BR0206463B1 (pt) compressor com chapa em z.
NO20015216D0 (no) Hjelpekran
FR2862981B1 (fr) Nouvelle souche de coronavirus associe au sras et ses applications
DK1383796T3 (da) Neurovirulent stamme af viruset West Nile og anvendelser heraf
ITBO20020534A1 (it) Carrello elevatore semovente, kit per la costruzione
ATE448008T1 (de) Transportables spieltor
DE50206876D1 (de) Titan-Zirkonium-Legierung
SE0101519D0 (sv) Nucleic ACID
HK1053684A1 (en) Girder bridge.
DK1423429T3 (da) Antistoffer mod caspase-8 og deres fremstilling og anvendelse
DE602004004258D1 (de) Acrylierte naturharze

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829